• Topotecan HCl for Antitumor Workflows: Mechanism to Optimiza

  2026-06-01

  Topotecan HCl enables robust, reproducible antitumor assays by leveraging topoisomerase 1 inhibition and quantifiable DNA damage. Discover data-driven workflow enhancements, troubleshooting strategies, and reference study insights that elevate research in lung and prostate cancer models.

• Syringin Natural Product: Applied Protocols and RCC Research

  2026-06-01

  The Syringin natural product empowers researchers to precisely modulate signaling pathways and apoptosis in advanced RCC models. This article translates bench-proven workflows and troubleshooting strategies, enabling robust bioactive compound screening and greater reproducibility in natural product research.

• Erastin (SKU B1524): Reliable Ferroptosis Inducer for Cancer

  2026-05-31

  This article delivers scenario-driven guidance for laboratory scientists investigating ferroptosis and oxidative stress with Erastin (SKU B1524). Drawing on validated protocols, comparative insights, and recent literature, it demonstrates how Erastin ensures reproducibility and sensitivity in cancer biology research workflows.

• KR-12 Human Antimicrobial Peptide: Protocols and Applied Ins

  2026-05-30

  KR-12 (human) TFA is the minimal, potent LL-37 fragment with targeted antimicrobial, anti-biofilm, and immunomodulatory activities. This guide details protocol-ready workflows, troubleshooting solutions, and translational insights—empowering researchers to fully leverage KR-12’s unique properties against multidrug-resistant pathogens and inflammatory models.

• Metronidazole as an OAT3 Inhibitor: Precision in Drug-Drug I

  2026-05-29

  Explore the multifaceted role of Metronidazole as a potent OAT3 inhibitor and nitroimidazole antibiotic in drug-drug interaction research. This article offers a deeper comparative analysis, mechanistic insights, and advanced assay guidance beyond existing protocols.

• Cyanine 3 Tyramide: A High-Sensitivity Fluorescent Dye for B

  2026-05-29

  Cyanine 3 Tyramide is a robust fluorescent dye for biomedical research, enabling ultrasensitive signal amplification in immunohistochemistry, in situ hybridization, and flow cytometry. APExBIO's K1085 kit supports sustained reagent stability and high reproducibility, making it a reliable choice for demanding fluorescence labeling workflows.

• Optimized Sulfonamide Derivatives Target M. tuberculosis wit

  2026-05-28

  Chen et al. present a systematic structure–activity optimization of sulfaphenazole-derived sulfonamides for antimycobacterial activity, achieving potent inhibition of Mycobacterium tuberculosis with minimized CYP 2C9 enzyme interference. Their approach advances the development of safer, more selective agents for TB treatment regimens.

• Dorsomorphin (Compound C): Selective AMPK and BMP Pathway In

  2026-05-28

  Dorsomorphin (Compound C) is a potent, reversible ATP-competitive AMPK inhibitor with high selectivity and validated activity in both metabolic and bone morphogenetic protein (BMP) signaling research. Peer-reviewed and product data confirm its efficacy in autophagy regulation, iron metabolism, and stem cell differentiation.

• Reelin-SFK Signaling: A Prerequisite for Ketamine’s Antidepr

  2026-05-27

  This study uncovers a critical requirement for intact synaptic Reelin signaling—specifically, the Reelin-Apoer2-Src family kinase (SFK) pathway—in mediating ketamine’s rapid antidepressant and synaptic effects. Disruption of Reelin or its downstream effectors prevents ketamine-induced hippocampal plasticity, offering crucial mechanistic insight for treatment-resistant depression research.

• SN-38 Disrupts FUBP1–FUSE Binding: Dual Action in Cancer Mod

  2026-05-27

  This study reveals that camptothecin and its analog SN-38, beyond their established role as DNA topoisomerase I inhibitors, directly inhibit the oncogenic transcriptional regulator FUBP1 from binding to its DNA target FUSE. These findings expand the mechanistic understanding of SN-38 in advanced colon and liver cancer research, providing a new molecular rationale for targeting transcriptional regulation alongside classic topoisomerase I inhibition.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-05-26

  This study demonstrates that Agatoxin-IVA-sensitive calcium channels mediate both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons in the nucleus ambiguus. The findings clarify the dominant role of P/Q-type channels in neurotransmission underlying cardiorespiratory control, with implications for neurophysiology and targeted synaptic research.

• Laminin (925-933): Protocols for Cell Adhesion and Migration

  2026-05-26

  Laminin (925-933) enables reproducible, receptor-specific dissection of cell adhesion and migration in vitro, particularly where defined, minimal extracellular matrix signals are needed. It is not suitable for diagnostic or therapeutic use, nor does it replicate the full spectrum of multivalent interactions provided by intact basement membrane proteins.

• XPO1 Inhibition by Eltanexor Disrupts Wnt/β-catenin in CRC M

  2026-05-25

  The reference study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer tumorigenesis by modulating the Wnt/β-catenin pathway and lowering COX-2 expression. These results provide mechanistic and in vivo evidence for XPO1 inhibition as a chemopreventive strategy in colorectal cancer, with translational implications for preclinical research.

• Ibuprofen: Applied Protocols for Apoptosis and Cell Cycle Ar

  2026-05-25

  Harness Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) for precise, reproducible induction of apoptosis and cell cycle arrest in colon carcinoma and lipid metabolism models. This guide details advanced workflows, troubleshooting, and the latest translational insights—bridging mechanistic understanding with optimized research protocols.

• Disulfiram in Synthetic Lethality: Precision Tools for Cance

  2026-05-24

  Explore how Disulfiram, a dopamine β-hydroxylase inhibitor, enables synthetic lethality strategies in APC-deficient colorectal and breast cancer research. This in-depth guide reveals unique mechanistic insights, protocol parameters, and translational opportunities for advanced oncology studies.

449 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page